The American Medical Association is seeking a measure requiring a waiting period before new prescription drugs or implantable devices are advertised. Last year, the drug industry adopted guidelines to delay consumer ad campaigns until after a drug company had educated doctors about its new drugs or devices. However, those guidelines are voluntary. At its annual meeting, the AMA adopted a proposal that the FDA and drug manufacturers devise waiting periods for each new drug or device before consumer ads are allowed. This a compromise from the AMA’s previous consideration of proposing a total ban on direct-to-consumer advertising. Seehttp://www.cnn.com/2006/HEALTH/06/14/doctors.drugs.ads.ap/index.html
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.